​Sarah Chamberlain joined BCG in 2014 in the Seattle office. She is a core member of the Health Care and Social Impact practice areas and focuses on Global Health. Sarah works with a major global health foundation and its grantees on a range of topics, with particular focus on maternal & reproductive health, primary care, and R&D.

​Sarah Chamberlain holds a PhD in Bioengineering from the University of Washington where she was a was a National Science Foundation Fellow and contributed to the development and characterization of a gene therapy for the treatment of heart failure, and a Bachelor of Arts in Biology from Williams College.